Levemir (Novo Nordisk)


Welcome to the PulseAid listing for the Levemir drug offered from Novo Nordisk. This Insulin [Chemical/Ingredient],Insulin Analog [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Novo Nordisk
NON-PROPRIETARY NAME: insulin detemir
SUBSTANCE NAME: INSULIN DETEMIR
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Insulin [Chemical/Ingredient],Insulin Analog [EPC]
ROUTE: SUBCUTANEOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2006-03-27
END MARKETING DATE: 0000-00-00


Levemir HUMAN PRESCRIPTION DRUG Details:

Item DescriptionLevemir from Novo Nordisk
LABELER NAME: Novo Nordisk
DEA SCHEDULE:
ACTIVE STRENGTH: 100([iU]/mL)
START MARKETING DATE: 2006-03-27
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0169-3687_a0ad4ce8-1e36-4b1f-bcd2-d73a8680d764
PRODUCT NDC: 0169-3687
APPLICATION NUMBER: NDA021536

Other INSULIN DETEMIR Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Dispensing Solutions, Inc.Levemir
Novo NordiskLevemir
Physicians Total Care, Inc.Levemir